
Writer
Kirti Kumbhar
M. Pharm QA
Kirti Kumbhar is an M.Pharm graduate with experience in Quality Assurance at Lupin Limited and a strong interest in clinical research, regulatory affairs, and Trial Master File (TMF) management. She has developed knowledge of regulatory documentation, quality systems, compliance, and healthcare research through her professional experience. Passionate about clinical development and continuous learning, Kirti is committed to supporting high-quality healthcare documentation, regulatory excellence, and research-driven healthcare advancements.
109
Articles written or reviewed
About Kirti
Kirti Kumbhar (M. Pharm QA) is a writer at Pharmacally, with 109 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Kirti Kumbhar
Health TidingsREMODEL Trial Identifies Potential Mechanisms of Semaglutide’s Kidney-Protective Effects
Clinical TrialsRademikibart Reduces Treatment Failure by 81% in Phase 2 COPD Exacerbation Study
Clinical TrialsRetatrutide Shows Up to 20.8% Weight Loss and A1C Reduction in TRIUMPH-2 Trial
Clinical TrialsAscletis’ ASC50 Shows Sustained PASI Reduction, Supporting Longer-Duration IL-17A Inhibition
New Drug ApprovalAbbVie’s Jumvo (Tavapadon) Receives FDA Approval for Parkinson’s Disease
Clinical TrialsCSPC’s Becotatug Plus Osimertinib Shows Positive Results in EGFR Exon 20 Insertion NSCLC
Drugs Safety AlertFDA Approves Boxed Warning for Adzynma Over Antibody Risk
Mergers & AcquisitionsEnvisagenics, Boehringer Partner on RNA Splicing Cancer Targets
Clinical TrialsRilzabrutinib Sustains Platelet Responses in LUNA3 ITP StudyOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala